Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (Recent Meetings/Call Summaries)
m
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Co-chairs: Sean Fain, PhD; Charles Hatt, PhD; Miranda Kirby, PhD
+
:Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD
 
:RSNA Staff Support: Julie Lisiecki
 
:RSNA Staff Support: Julie Lisiecki
 
* [http://tinyurl.com/QIBA-CT-Lung-Density-Roster Roster]
 
* [http://tinyurl.com/QIBA-CT-Lung-Density-Roster Roster]

Revision as of 17:50, 23 February 2021

Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD
RSNA Staff Support: Julie Lisiecki

Scope

Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.

Recent Meetings/Call Summaries

Lung Density/COPD BC Call Summaries Archive

Profile Development

Status - <summarize current status>

A Google link for Public Comment Resolution has been created for ease of sharing updates with the group: https://docs.google.com/document/d/1uOzBaB_77vLSv8FKtQ59AxpfcAswtJ4t/edit#heading=h.gjdgxs


Archive - Lung Density

Protocol Development Activities


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Working Documents


Reference Documents


QIBA Funded Projects

Round 2

Round 4

Round 5

Round 6